A potential treatment of COVID-19 with TGF-β blockade

Int J Biol Sci. 2020 Apr 21;16(11):1954-1955. doi: 10.7150/ijbs.46891. eCollection 2020.

Author

Affiliation

¹ Mucosal Immunology Section, NIDCR, National Institutes of Health, Bethesda, MD 202892, USA.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Intramural

MeSH terms

COVID-19
Coronavirus Infections / drug therapy*
Coronavirus Infections / immunology
Coronavirus Infections / pathology
Fibrosis / drug therapy
Humans
Immunotherapy
Inflammation / drug therapy
Lung / immunology
Lung / pathology
Pandemics
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / immunology
Pneumonia, Viral / pathology
Transforming Growth Factor beta / antagonists & inhibitors*

Substances

Transforming Growth Factor beta